Increasing Infertility and presence of surrogacy market can further boost IVF Market by 2022
In recent times, there has been a huge increase in the demand for the Assisted Reproductive Techniques (ART). Infertility is the main cause for escalating the demand of Arts which is caused due to rapid change in lifestyle, smoking drinking, steroids, mental stress/trauma and other medical conditions like diabetes, cystic fibrosis, trauma, testicular failure, and fallopian tube blockage, ovarian dysfunction in females, etc. Therefore, these factors are supporting the growth and development of IVF market.
To track the trends of the IVF market globally, BIS Research study includes qualitative and quantitative analysis of the market. The qualitative models of the market include industry attractiveness analysis, and market dynamics, among others. Industry attractiveness analysis provides an in-depth analysis of the level of competitiveness IVF market players. The market dynamics section summarizes the overall trend analysis of the market. The market dynamics section describes the factors driving and restraining the market growth, including the opportunities in the IVF market. The report also provides a comprehensive study of the prominent regulations, consortiums, patents and standards of the global IVF market.
Studied IVF market in our report coverage includes markets byprocedure, instruments, reagents &media, and geographies. The above mentioned sections have been analyzed quantitatively and the market value is evaluated and discussed in their respective sections in this report.
The answers to the following key questions can be found in the report: - What are the major market drivers, challenges and opportunities of the IVF market and their use cases?
- What are the key trends and developments in the IVF market for genetic disease management?
- What are the different types of instruments, reagents and media used in the IVF procedures?
- How will the key market players leverage on key developments such as mergers and acquisitions, partnerships, and product launches among others?
- Which geographical region will lead the global IVF market by the end of the forecast period?
- Who are the key players in the global IVF market?
- What are the recent key market trends and key developments in different geographical regions?
- What are the different procedures present in IVF market?
- What is the global and regional market for IVF through 2022?
- What is the status of IVF in developed, developing and other countries?
The report includes the profiles of major players in the IVF market that allows the readers to gain an insight into the various industry trends.
Executive Summary High infertility rate and degrading reproductive health conditions have triggered the development of Assisted Reproductive Technology (ART) in the early 1990s. There are copious benefits of these techniques such as prevention of communicable diseases, genetic or hereditary disorders among others. Due to these reasons, couples who are unable to bear children, have been compelled to adopt one or more ART methods for conceiving a child.
There are various types of ART techniques, among which the most frequently used techniques are In-Vitro fertilization (IVF), and Intra Uterine Insemination (IUI). The In-Vitro fertilization (IVF) technique, which is an amateur market, has the potential to be one of the biggest market boosters in the future.
The IVF process is directly related to the birth of a child, which is directly intertwined with the patient’s emotional and physical health. In many developing countries, the IVF market’s growth is restrained due to their cultural and ethical attitude towards this process. However, the government has introduced educational programs and regulations, which are contributing in building a platform, for the development of the IVF market.
The global IVF market includes pre-treatment drugs and lab equipment, instrument & reagents. In this report the pre-treatment drugs market is not taken into consideration. The global market is expected to grow over $26.08 billion by 2022. IVF Market can be further divided into various segments and sub-segments.
The IVF procedure market has been divided into four main categories viz. Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Zygote Intrafallopian transfer (ZIFT) and Gamete Intrafallopian Transfer (GIFT) among others. Globally ICSI is the most frequently used technology, and currently accounts for two-third of the world's IVF market. Market share of ICSI is expected to decline in the future due to increasing investments in Frozen Embryo Replacement (FER) which is preferred by various end users like armed forces personnel and High Net worth Individual (HNI) among others.
Due to their limited applications, ZIFT and GIFT procedures reserve a small market share. These procedures are used only in special cases where the first IVF cycle is unsuccessful or the mother is facing serious issues in conceiving. Both these procedures are invasive, and thus, are less preferred in developed countries.
European countries prefer IVF treatments and egg donations, especially Spain which has highest number of egg donors, followed by Poland and Ukraine. In countries like the U.S., the U.K., Spain, France, and Denmark, the donor number has doubled in a span of 10 to 15 years. Moreover, the availability of skilled personnel, high quality of treatments at economical prices, and increasing awareness of IVF treatments are some of the major factors that are contributing to the growth of the European IVF market.
The increasing infertility cases, advancement of technologies, government support & regulations, educational awareness programs, and emerging reimbursement policies are some of the major factors driving the growth trajectory of this market. The development of pre-implantation diagnosis tests are helping parents to know about the well being of their baby in early stages of pregnancy and hence are foreseen as a viable opportunity for this market.
Our reports have been used by over 10K customers, including:
The global surrogacy market reached a value of US$ 161.83 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 240.56 Million by 2027, exhibiting a CAGR of 6.62% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at a CAGR of 13.1% during 2021-2028. The report highlights trends prevailing in the market and the factors driving it.The growth of the frozen tissues samples market is attributed to the...
The global carrier screening market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
The global immunoglobulin market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments...
Oxygen-Infused Innovation - ForeSights Summary "Oxygen-Infused Innovation - ForeSights" explores an element that is breathing new life into consumer product innovation. Oxygen plays a critical role in metabolism and respiration; however, it is being leveraged in a more explicit way across...
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
17 pages •
By Euromonitor International
• Mar 2021
Natural increase will boost population expansion in Colombia in 2020-2040. Low and falling birth rates and rising longevity will accelerate the ageing trend impacting consumer trends, as older groups expand rapidly. Urbanisation will hasten with Bogota remaining the dominant city. Colombia has the potential to become a progressively more attractive...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.